Search Results
Jun 03, 2026, 15:33 ET EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM
MJ, Cho BC, Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147:237-243.Internationale
More news about: Amgen
Jun 03, 2026, 15:30 ET Cambium bringt ApexShield 3000 auf den Markt: Eine Schutzbeschichtung mit doppeltem Verwendungszweck , die für Hochtemperaturleistungen entwickelt wurde
lösungsmittelbasierte 1-Komponenten-Flüssigkeit, die bereits bei Temperaturen von 215°C (419°F) aushärtet und eine anhaltende Betriebsleistung bis 315°C (600°F) bietet, mit einer Kurzzeitfähigkeit bis 427°C (800°F). Das System erfordert keine Kühllagerung und ist in Quarts, Gallonen und Fässern erhältlich
More news about: Cambium Biomaterials, Inc
Jun 03, 2026, 15:16 ET LA COMMISSION EUROPÉENNE APPROUVE IMDYLLTRA® D'AMGEN POUR LE TRAITEMENT DU CANCER DU POUMON À PETITES CELLULES DE STADE ÉTENDU
MJ, Cho BC, Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147:237-243.International
More news about: Amgen
Jun 03, 2026, 14:25 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC
Cho BC, Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023; 389 (22): 2063 – 2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147: 237
More news about: Amgen
Jun 03, 2026, 13:35 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK IMDYLLTRA® OD SPOLEČNOSTI AMGEN K LÉČBĚ EXTENZIVNÍHO STADIA MALOBUNĚČNÉHO KARCINOMU PLIC
Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147:237-243.International
More news about: Amgen
Jun 03, 2026, 13:05 ET Los Angeles Public Library Hosts Fourth Annual June Jubilee: A Celebration of Black Excellence
experience in Los Angeles."The Library's June Jubilee is a vibrant celebration of community, culture, and connection," said City Librarian John F. Szabo. "We are proud to honor Black history, storytelling, music, art, and shared experiences. From preserving personal histories through the CommUnity
More news about: Los Angeles Public Library
Jun 03, 2026, 12:14 ET SKINCEUTICALS TORNA-SE PARCEIRA OFICIAL DE CUIDADOS COM A PELE DA SCUDERIA FERRARI HP
ativações exclusivas no local em corridas selecionadas do Grand Prix em todo o mundo, trazendo o produto e a identidade clínica da marca para o mundo da F1."Estamos orgulhosos de receber a SkinCeuticals como parceira oficial de cuidados com a pele da Scuderia Ferrari HP", disse Lorenzo Giorgetti, diretor
More news about: SkinCeuticals
Jun 03, 2026, 12:04 ET RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak
statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 20-F filed with the SEC on April 27, 2026. All forward-looking statements included in this press release are made only as of the date of this press release.
More news about: RedHill Biopharma Ltd.
Jun 03, 2026, 12:00 ET Climate change is increasing the risk of slower games and reduced player performance at nearly every 2026 World Cup match
performance-impairing heat during the 2026 FIFA World Cup, according to a new Climate Central analysis. By examining the odds of temperatures exceeding 82.4°F (28°C) — a threshold linked to declines in player performance — researchers found that 97 of the 104 scheduled matches now face a higher probability of
More news about: Climate Central
Jun 03, 2026, 11:39 ET Point of Care Testing Market Poised for US$ 64.8 Bn Valuation by 2031, Growing at 7.5% CAGR, New Report by Wissen Research
monitoring, and handheld POCT systemsF. Hoffmann-La Roche Ltd (Switzerland)Molecular
More news about: Wissen Research LLC
Jun 03, 2026, 10:47 ET The $1 Billion Bet to Take Fusion Public
offering, which was filed with the SEC on September 4, 2025 (the "Final Prospectus"); the risks described in the joint registration statement on Form F-4 filed by General Fusion and SVAC, as amended (the "Registration Statement"), which includes a preliminary proxy statement/prospectus, or to be described
More news about: Equity Insider
Jun 03, 2026, 10:34 ET THE 27TH ANNUAL BEST BUDDIES CHALLENGE: HYANNIS PORT PRESENTED BY JERSEY MIKE'S SUBS, SHAW'S AND STAR MARKET FOUNDATION AND THE TJX COMPANIES, INC. RAISES MORE THAN $4 MILLION TO SUPPORT PEOPLE WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
The Challenge kicked off on Friday, May 29 with a private dinner reception at the John F. Kennedy Presidential Library & Museum in Boston. During the reception, Jersey Mike's Founder Peter Cancro announced the launch of the
More news about: Best Buddies International
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
(Tarlatamab u pacjentów z wcześniej leczonym drobnokomórkowym rakiem płuca). N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer (Międzynarodowe
More news about: Amgen
Jun 03, 2026, 10:16 ET KCC Companies Accelerates Direct-to-Market Growth, Opens Channel Partner Conversations Across North America
920–compliant dedicated outdoor air systems (DOAS) delivering up to 100 percent conditioned outdoor air with the ability to maintain supply dewpoints down to 43°F, at all ambient conditions. Part-load performance is where the specification is won: the integrated seasonal moisture removal efficiency (ISMRE2) ratings
More news about: KCC Manufacturing
Jun 03, 2026, 10:11 ET DXC, 금융기관 핀테크 생태계 연결과 확장을 도와주는 DXC CoreIgnite 출시
multimedia:https://www.prnewswire.com/kr/news-releases/u0064u0078u0063u002Cu002DuAE08uC735uAE30uAD00u002DuD540uD14CuD06Cu002DuC0DDuD0DCuACC4u002DuC5F0uACB0uACFCu002DuD655uC7A5uC744u002DuB3C4uC640-302790325.htmlSOURCE
More news about: DXC Technology Company
Jun 03, 2026, 10:06 ET From the Flight Line to the Index: Starfighters Space (FJET) Joins the Russell 3000®
Operating from NASA's Kennedy Space Center in Florida, Starfighters Space maintains what it describes as the world's only commercial fleet of flight-ready F-104 supersonic aircraft capable of sustained MACH 2+ operations. That fleet is the foundation of a deliberately different approach to reaching the edge
More news about: USA News Group
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
MJ, Cho BC, Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147:237-243.International
More news about: Amgen
Jun 03, 2026, 09:30 ET TAT Technologies Secures $45 Million in Long-Term MRO Contract Awards
and other risks detailed from time to time in the Company's filings with the Securities Exchange Commission, including, its annual report on form 20-F and its periodic reports on form 6-K. These documents contain and identify other important factors that could cause actual results to differ materially
More news about: TAT Technologies Ltd
Jun 03, 2026, 09:28 ET MetaOptics Ltd 關於擬議於納斯達克證券交易所進行雙重上市之最新進展
9MT)（「MetaOptics」或「本公司」，連同其子公司統稱「本集團」）謹此向本公司股東（「股東」）匯報，本公司就擬議於納斯達克證券交易所作雙重上市的計畫目前仍按原定時間表推進，並將就任何重大進展情況持續向股東作出更新。 如本公司於2026年5月19日之公告所述，本公司已於2026年5月18日根據美國《證券法》向美國證券交易委員會（SEC）提交經修訂之Form F‑1 註冊聲明（「註冊聲明」），以反映包括擬發行之美國預託股份（ADSs）的數量，以及每一發售ADS所代表之標的股份數目及其換算比例等事項。本公司已於2026年5月28日接獲新加坡證券交易所有限公司（「新交所」）就本公司擬發行新普通股（「新股」）並在本公司股本中上市及掛牌買賣所發出的上市及報價資格預審通知書（listing
More news about: METAOPTICS LTD
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung
More news about: Amgen
Jun 03, 2026, 09:26 ET MAHA PAC Celebrates Historic Victory as Zach Lahn Wins Iowa Republican Primary for Governor
victory reflects mounting grassroots momentum behind the Make America Healthy Again movement led nationally by Health and Human Services Secretary Robert F. Kennedy Jr. and focused on rebuilding public trust in health institutions, eliminating chronic disease, protecting children from environmental toxins,
More news about: MAHA PAC
Jun 03, 2026, 09:15 ET Xiao-I Corporation Regains Full Compliance with Nasdaq Continued Listing Standards
Additional factors are discussed in the Company's filings with the SEC, including under the section entitled "Risk Factors" in its annual report on Form 20-F/A filed with the SEC on May 22, 2026, as well as its current reports on Form 6-K and other filings, all of which are available for review at
More news about: Xiao-I Corporation
Jun 03, 2026, 09:00 ET Cambium Launches ApexShield 3000: A Dual-Use Protective Coating Engineered for High-Temperature Performance
is a sprayable, solvent-based 1-part liquid that cures at temperatures as low as 215°C (419°F) and delivers sustained operational performance up to 315°C (600°F), with short-duration capability up to 427°C (800°F). The system requires no refrigerated storage and is available in quarts, gallons, and drums,
More news about: Cambium Biomaterials, Inc
Jun 03, 2026, 09:00 ET Cambium Launches ApexShield 3000: A Dual-Use Protective Coating Engineered for High-Temperature Performance
is a sprayable, solvent-based 1-part liquid that cures at temperatures as low as 215°C (419°F) and delivers sustained operational performance up to 315°C (600°F), with short-duration capability up to 427°C (800°F). The system requires no refrigerated storage and is available in quarts, gallons, and drums,
More news about: Cambium Biomaterials, Inc
Jun 03, 2026, 09:00 ET Getac's new 8-inch ZX80W tablet blends Windows 11 functionality with energy-efficient fanless design for all-day productivity in the field
IP67 certified, vibration, and 6ft (1.8m) drop resistant. It also features a sunlight-readable display and a wide operating temperature range of -20°F to 145°F (-29°C to 63°C). Despite all this, the ZX80W weighs just 1.3lbs (590g), making it incredibly lightweight for extended use in the field."Effective
More news about: Getac Technology Corporation